Prevention of cholesterol gallstone disease by FXR agonists in a mouse model

Antonio Moschetta, Angie L. Bookout, David J. Mangelsdorf

Research output: Contribution to journalArticle

230 Scopus citations

Abstract

Cholesterol gallstone disease is characterized by several events, including cholesterol precipitation in bile, increased bile salt hydrophobicity and gallbladder inflammation. Here, we describe the same phenotype in mice lacking the bile acid receptor, FXR. Furthermore, in susceptible wild-type mice that recapitulate human cholesterol gallstone disease, treatment with a synthetic FXR agonist prevented sequelae of the disease. These effects were mediated by FXR-dependent increases in biliary bile salt and phospholipid concentrations, which restored cholesterol solubility and thereby prevented gallstone formation. Taken together, these results indicate that FXR is a promising therapeutic target for treating or preventing cholesterol gallstone disease.

Original languageEnglish (US)
Pages (from-to)1352-1358
Number of pages7
JournalNature medicine
Volume10
Issue number12
DOIs
StatePublished - Dec 1 2004

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Prevention of cholesterol gallstone disease by FXR agonists in a mouse model'. Together they form a unique fingerprint.

  • Cite this